Skip to main content
SpringerLink
Log in

Biological grafts as arterial substitute in the infragenicular level: A prospective evaluation

  • Original Articles
  • Published:
International Journal of Angiology

Abstract

In order to evaluate patency and clinical success rates, foot salvage rates, and complications associated with the use of two biological graft conduit materials, the authors performed a prospective study of 109 femoroinfrageniculate bypasses performed over six years. The two grafts studied as arterial substitutes were chemically processed human umbilical vein (HUV) graft and ovine collagen graft (OCG). Indications for surgery were disabling claudications (11%), acute ischemia (20%), rest pain (35%), and nonhealing ulceration or gangrene (34%). Sixty-two (57%) operations were repeat procedures for occluded grafts. Major complications occurred in 11.9%: 4 deaths, 1 acute renal failure, 4 graft infections, 4 anastomotic hemorrhages, and 1 case of inadequate graft rinsing. There were 39 early occlusions, which resulted in one-month primary patency rates of 59% (OCG) and 69% (HUV) and secondary patency rates of 71% (OCG) and 87% (HUV). The primary and secondary patency rates at two years were 47% and 58% for OCGs, 42% and 58% for HUVs. The mean foot salvage rates at one month were 82.5% (OCG) and 95.3% (HUV) and at one year were 73% (OCG) and 82% (HUV). These results did not show statistically relevant differences between the two graft materials (chi square = 0.891,p>0.1). Acute ischemia was associated with a higher percentage of failure when compared with chronic ischemia, but significance was not reached (chi square = 2.77,p=0.10). However, patients with repeat procedures were associated with higher rates of failure than those undergoing primary procedures (chi square = 5.12,p=0.025).

Although both types of biograft showed relatively good attrition rates over time, a high early occlusion rate, possibly due to material thrombogenicity, had a detrimental effect on the early patency rate. These results emphasize the importance of autogenous vein grafts for repeat procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Batt M, Avril G, Gagliardi JM, et al. (1990) Femorodistal bypass using the chemically processed human umbilical vein graft: A 9-year experience. Can J Surg 33:61–65.

    PubMed  Google Scholar 

  2. Berger K, Sauvage LR, Rao AM, et al. (1972) Healing of arterial prostheses in man; its incompleteness. Ann Surg 175:118–127.

    PubMed  Google Scholar 

  3. Bull PG, Denck H (1991) Angioplastie transluminale corrélée avec une revascularisation fémoropoplitée: Suivis à long terme. Angiologie 139:1832–1833.

    Google Scholar 

  4. Bull PG, Denck H, Guidoin R, et al. (1992) Preliminary clinical experience with polyurethane vascular prostheses in femoropopliteal reconstructions. Eur J Vasc Surg 6:217–224.

    PubMed  Google Scholar 

  5. Bull PG, Mendel H, Hold M, et al. (1992) Distal popliteal and tibioperoneal transluminal angioplasty: Long-term follow-up. J Vasc Intervent Radio 3:45–53.

    Google Scholar 

  6. Charara J, Beaudoin G, Fortin C, et al. (1989) In vivo stability of four types of arterial grafts with impervious wall; their haemodynamic and pathological characteristics. J Biomed Eng 11: 416–428.

    PubMed  Google Scholar 

  7. Christie BA, Ketharanathan V, Perlof LJ (1980) Patency rates of minute vascular replacements: The glutaraldehyde modified mandrill-grown conduit. J Surg Research 28:519–521.

    Article  Google Scholar 

  8. Dardik H, Miller N, Dardik A, et al. (1988) A decade of experience with the glutaraldehyde-tanned human umbilical cord vein graft for revascularization of the lower limb. J Vasc Surg 7:336–346.

    Article  PubMed  Google Scholar 

  9. Eickhoff JH, Buchardt Hansen HJ, Bromme A, et al. (1983) A randomized clinical trial of PTFE versus human umbilical vein for femoropopliteal bypass surgery: Preliminary results. Br J Surg 70:85–88.

    PubMed  Google Scholar 

  10. Gagnon Y, Guidoin R, Downs AR, et al. (1986) The virgin, modified, human umbilical vein graft: Morphologic characteristics and mechanical properties. Can J Surg 29:411–418.

    PubMed  Google Scholar 

  11. Hagmueller GW. (1981) Clinical and experimental studies of bloodflow changes during reconstruction of the femoropopliteal arterial axis. Angio Archiv. Thesis, Demeter-Verlag, Germany.

    Google Scholar 

  12. Hagmueller GW, Teiner G, Denck H (1986) Erste erfahrung mit schafskollagenprothesen (omniflow) im femoropopliteocruralen abschnitt. Anglo Archiv 11:119–122.

    Google Scholar 

  13. Harris JP, Farey I, Stephens MS, et al. (1984) Limitations of human umbilical vein grafts. Surgery 100:23–28.

    Google Scholar 

  14. Julien S, Gill F, Guidoin R, et al. (1989) Biologic and structural evaluation of 80 surgically excised human umbilical vein grafts. Can J Surg 32:101–107.

    PubMed  Google Scholar 

  15. Karkow WS, Cranley JJ, Cranley RD, et al. (1986) Extended study of aneurysm formation in umbilical vein graft. J Vasc Surg 4:486–492.

    Article  PubMed  Google Scholar 

  16. Ketharanathan V, Christie BA (1980) Glutaraldehyde-tanned ovine collagen conduits as vascular xenografts in dogs. Arch Surg 115:967.

    PubMed  Google Scholar 

  17. Klimach O, Charlesworth D (1983) Femorotibial bypass for limb salvage using human umbilical vein. Br J Surg 70:1–3.

    PubMed  Google Scholar 

  18. Kretschmer G, Wenzel E, Wagner O, et al. (1986) Influence of anticoagulation treatment in preventing graft occlusion following saphena vein bypass for femoro-popliteal occlusive disease. Br J Surg 73:689–692.

    PubMed  Google Scholar 

  19. Landefeld CS, Goldman L (1989) Major bleeding in outpatients treated with warfarin: Incidence and prediction by factors known at the start of outpatient therapy. Am J Med 87:144.

    PubMed  Google Scholar 

  20. Largiadèr J (1988) Reconstructive surgery of crural arteries in limb-threatening ischemia. Schweiz Med Wochenschr 118:1272–1282.

    PubMed  Google Scholar 

  21. McCollum C, Kenchington G, Alexander C, et al. (1991) PTFE or HUV for femor-popliteal bypass: A multi-centre trial. Eur J Vasc Surg 5:435–443.

    PubMed  Google Scholar 

  22. Megerman J, Abbott WM (1989) Clinical importance of the compliant conduit. In: Vascular Dynamics, Westerhof N, Gross DR (eds). Plenum: New York, pp 263–276.

    Google Scholar 

  23. Michaels JA (1989) Choice of material for above-knee femoropopliteal bypass graft. Br J Surg 76:7–14.

    PubMed  Google Scholar 

  24. Moritz A, Grimm M, Eybl E, et al. (1991) Verbesserung der spontanendothelisierung und glutaraldehydfixierten bovinen perikargrafts und humanen nabelschnurvenen durch detoxifizierende nachbehandlung. Angio Archiv 20:27–30.

    Google Scholar 

  25. Peto R, Piki MC, Armitage P, et al. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Br J Cancer 35:1–39.

    PubMed  Google Scholar 

  26. Rosenberg DML, Glass BA, Rosenberg N, et al. (1970) Experience with modified carotid arteries in arterial surgery. Surgery 68:1064–1072.

    PubMed  Google Scholar 

  27. Rutherford RB, Flanigan DP, Gupta SK, et al. (1986) Suggested standards for reports dealing with lower extremity ischemia. Ad Hoc Committee on Reporting Standards for Vascular Surgery. J Vasc Surg 4:80–94.

    Article  PubMed  Google Scholar 

  28. Wandschneider W, Bull PG, Denck H (1988) Anastomotic aneurysms—an unsolvable problem. Eur J Vasc Surg 2:115–119.

    PubMed  Google Scholar 

  29. Wiebe D, Megerman J, L'Italian GJ, et al. (1988) Glutaraldehyde release from vascular prostheses of biologic origin. Surgery 104:26–33.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. First Department of Surgery, Krankenhaus Wien-Lainz, Vienna, Austria

    Michael Hold M.D., Georg W. Hagmueller M.D. & Wolfgang Wandschneider M.D.

  2. Second Department of Surgery, Wilhelminenspital, A-1171, Vienna, Austria

    Philippe G. Bull M.D. (F.I.C.A.)

Authors
  1. Philippe G. Bull M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael Hold M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Georg W. Hagmueller M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wolfgang Wandschneider M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Supported in part by a grant from the Scientific Foundation of the City of Vienna

The English content of this paper has been reviewed by Mr. Robert Nicholson, Berlitz Institute, Vienna, Austria

About this article

Cite this article

Bull, P.G., Hold, M., Hagmueller, G.W. et al. Biological grafts as arterial substitute in the infragenicular level: A prospective evaluation. International Journal of Angiology 3, 77–85 (1994). https://doi.org/10.1007/BF02014919

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02014919

Keywords

Search

Navigation